Skip to main content

Table 1 Participants’ demographic and clinical characteristics

From: Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid

Participants
(n = 23)
 
Age, years: mean (s.d.) range 43 (10) 25–58
Male: n (%) 16 (70)
Employment, n (%)
 Employed, full/part-time 3 (13)
 Unemployed/DLA or incapacity benefit 20 (87)
Ethnicity, n (%)
 British, White 11 (48)
 British, Carribean 7 (30)
 British, mixed 1 (5)
 Other 4 (17)
Location of recruitment, n (%)
 Community mental health teams 22 (96)
 Specialist mood disorders clinic 1 (4)
Diagnosis received, n (%)
 Schizophrenia 20 (87)
 Schizoaffective disorder 2 (8)
 Bipolar II disorder 1 (4)
Medication Taken, n (%)
 Clozapine 11 (47)
 Paliperidone 4 (17)
 Risperidone 3 (13)
 Aripiprazole 2 (9)
 Olanzapine 1 (4)
 Quetiapine 1 (4)
 Chlorpromazine 1 (4)
 Amisulpride 1 (4)
 Citalopram 2 (8)
 Metformin 1 (4)
 Bendroflumethiazide 1 (4)
 Procyclidine 1 (4)
 Atorvastatin 1 (4)
 Zopiclone 1 (4)
 Clonazepam 1 (4)